Keyword: Medicare Payment Advisory Commission (MedPAC)
Medicare cut payments to 2,583 hospitals, continuing the Affordable Care Act’s campaign to financially pressure hospitals into reducing readmissions.
A new study found a nixed CMS proposal to give Part D plans more flexibility to drop protected-class drugs could have hampered patient access.
More brand-name discounts for drugs offered in Part D's "doughnut hole" could inadvertently stymie generic competition, a new Health Affairs study says.
MedPAC is urging Congress to adopt reforms to improve the quality of encounter data and boost beneficiaries’ access to primary care.
CMS Administrator Seema Verma said it will be crucial to have more conversations on how to address emerging—and expensive—therapies.
Part D drug spending continues to rise, and a government watchdog argues giving plan sponsors strong incentives to negotiate prices is a key solution.
Medicare Part D was launched before the rapid rise of pricey specialty drugs, so MedPAC is weighing a significant overhaul of the program.
MedPAC voted to approve a set of recommendations aimed at boosting the accuracy of Medicare Advantage encounter data.
MedPAC commissioners weighed what a Medicare without fee-for-service might look like at a meeting Thursday.
MedPAC warns in its March report to Congress that current Part D policy may encourage health plans to shirk responsibility for managing spending.